Appfinder Therapeutics
Anyang
About Appfinder Therapeutics
AppFinder Therapeutics is a biopharmaceutical company specializing in innovative platform technologies. It offers the PepFc® platform, a unique small peptide technology that can replace the Fc region of IgG antibodies, and the AbFinder® platform, which enables comprehensive antibody drug discovery and engineering for development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Funding stage: Seed
- Last round: Seed (Sep 2025)
- Website: abfindertrx.com?act=main
- Phone: 070-8064-1022
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/appfinder-therapeutics-2691841 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.